On track towards IVDR certification of our product portfolio
Devyser announced in Aug 2022 that we received our first IVDR certificate from the notified body...
IVDR | July 17, 2023
Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvals
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from kidney-transplant patients and its product for screening and follow-up of stem cell transplant patients fulfill...
Find out more
